Stopping Cancer at the Root Cause

A unique treatment method, Precision Medicine is a combination of biological and nanotechnologies that stop cancer at the root cause, preventing cancer growth and metastasis.

Learn About Our Tech

ARIZ Precision Medicine

ARIZ (an acronym) is a company dedicated to solving a big problem, cancer. The acronym stands for a methodology of solving big problems, by breaking the big problem into smaller and smaller problems. This way the company can start at the beginning, the cause of cancer and design drugs that can resolve a specific individual cancer as well as all cancers. ARIZ Precision Medicine uses this methodology to design a specific way to stop the cause of cancer, then target and protect the delivery system and finally, concentrate the drug inside the cancer cell leaving normal cells undamaged.

We deliver the right drug, to the right place, at the right time, with the right dose.

Learn more

Siddhartha Mukherjee, MD, 2011 Pulitzer Prize Winner, author of the Emperor of All Maladies: A Biography of Cancer stated that cancer cells have certain vulnerabilities that could be exploited.

These vulnerabilities include targeting the drivers of the cancer, genetic and epigenetic errors. ARIZ is targeting these initial errors in cancer and causing cancer cells to die, biologically.

ARIZ announces Seed round funding

November 3, 2020

ARIZ Precision Medicine, The PRDM Oncogene Targeting Company™ announced that it has secured seed financing bringing total funding to date of $2.5 million. Proceeds will be used to expand the management team as well as continue development of its proprietary PRDM-based product candidates for lung ca...

Read More News